Point of care (POC) laboratory testing is used to improve emergency department (ED) throughput but often overuses resources by duplicating formal laboratory testing. This study sought to evaluate the effect of a multimodal intervention on duplicate chemistry testing. This pre-post analysis included all visits to 2 urban EDs between June 2014 and June 2016. The multimodal intervention including provider education, signage, electronic health record redesign, and audit and feedback focused on reducing duplicate chemistry testing. The primary outcome was the number of duplicate chemistry tests per 100 visits. Autoregressive integrated moving-average models were used to account for secular changes. A total of 299 701 ED visits were included. The daily number of duplicate chemistry and POC chemistry tests significantly decreased following the intervention (3.3 fewer duplicates and 10.2 fewer POC per 100 ED visits, P < .0001). This implementation of a multimodal quality improvement intervention yielded substantial reductions in the overuse of blood chemistry testing in the ED.
Reducing unnecessary laboratory testing in health care facilities has become a key objective of quality improvement seeking to improve efficiency and reduce health care costs. 1 Several medical specialty societies have identified unnecessary laboratory testing as a target for overuse reduction in the Choosing Wisely campaign to avoid low-value care, [1] [2] [3] and a number of interventions have been implemented or proposed to reduce duplicate testing in hospitals. [4] [5] [6] [7] [8] [9] Although the Choosing Wisely campaign has gained international momentum, 1 recent research has shown mixed results of successful implementation with few publications demonstrating evidence of success in reducing both cost and workload for health care practitioners. [4] [5] [6] As the primary site of acute, unscheduled care, more than 70% of the 136 million annual emergency department (ED) visits in the United States involve laboratory testing, 10 and improving the efficiency of ED laboratory testing patterns has been identified as a target for highvalue emergency care. 2 Despite evidence of successful interventions to reduce duplicate testing in the inpatient hospital and intensive care settings, [4] [5] [6] 11, 12 previous work has not explored reducing unnecessary testing in the ED.
Prior work has demonstrated the importance of developing local targets to engage providers in the Choosing Wisely initiative. 13 In the study institution, ED providers identified duplicate chemistry testing as a high-priority target for overuse reduction. 14 The use of point of care (POC) laboratory testing in the ED to improve ED throughput has become widespread, 15, 16 resulting in duplicate testing and resource overuse because of clinical custom and provider mistrust of POC test accuracy. 17, 18 Although use of POC tests is often complicated by broad beliefs of imprecision or poor test characteristics, 19 the present work sought to overcome these barriers by building off a locally conducted quality improvement research project that demonstrated the high accuracy of POC tests prior to implementation of the intervention. 17 Therefore, an intervention was devised to reduce lowvalue duplicate testing based on prior quality improvement research demonstrating the effectiveness of multifaceted 1 Yale University, New Haven, CT 2 Yale New Haven Hospital, New Haven, CT interventions in the ED. Specifically, the study team incorporated evidence-based ED quality improvement techniques, including audit and feedback 20 and electronic health record (EHR) design, beyond traditional provider education. [21] [22] [23] The team sought to evaluate the effectiveness of this intervention on reducing duplicate chemistry testing in the ED and describe results to promote broader adoption of similar initiatives.
Methods

Design and Setting
Pre-post analysis of all visits to 2 urban EDs-one a tertiary academic center with an annual census of more than 90 000 visits and the other a community-based ED with an annual census of more than 60 000 visits-between June 2014 and June 2016. This study was exempt from institutional review board review.
Intervention
The 2-month multimodal quality improvement intervention was initiated in July 2015 at both EDs and consisted of provider education, signage, EHR redesign, and audit and feedback.
Provider Education. Education for emergency medicine attending physicians, residents, and physician assistants included the presentation of data demonstrating high agreement in clinically relevant values between POC and formal laboratory chemistry studies. 17 In addition, providers discussed waste associated with duplicate testing and personal approaches to chemistry testing at one faculty meeting, one resident education meeting, and one advanced practice provider staff meeting. Provider education for emergency nurses and medical technicians focused on waste reduction principles and communication scripting to prompt providers to "choose one chemistry." All providers received instruction on appropriate indications for each chemistry test and duplicate testing based on guidance from the departmental multidisciplinary Patient Safety and Quality Committee. The educational materials (brief PowerPoint presentation) also were distributed electronically to all faculty and residents for the benefit of those not in attendance. In addition to the primary educational session, providers also received brief educational reminders (<3 minutes) during the intervention at biweekly faculty meetings, monthly resident educational conference, and weekly nursing huddles in conjunction with presentation of audit-and-feedback reports.
Signage. Signage reinforcing efforts to reduce duplicate testing included messages to "pick one chemistry" or "choose your chemistry wisely." Signs were posted in provider break rooms, ED supply workrooms, and on computer screen savers. (See Supplementary Figure 1 , available online with this article).
EHR Redesign. The EPIC ASAP (Epic Systems Corporation, Verona, Wisconsin) ordering interface utilized in both EDs was modified to support this initiative. Modifications included removal of POC test orders from nursing order sets and placement of both chemistry tests visually adjacent to each other in standard order entry templates. Prior research found that EHR redesign can be an effective tool for improving clinical practice, 11, 12 particularly if EHR changes are designed to account for clinical thought processes to ensure success. 24 Duplicate testing alerts were not employed based on prior evidence of limited efficacy and substantial concern about alert fatigue. 25 Audit and Feedback. Group-and individual-level audit and feedback was supported by development of a clinical quality dashboard providing real-time data on duplicate testing by ED site and attending physician. Feedback was distributed to all providers via e-mail listservs, ED electronic billboards, and standing meetings. Feedback was distributed on a weekly basis during the 2-month intervention, and then monthly in September, October, and November 2015. Feedback was only distributed electronically, with both ED site and attending physician identified. Feedback was distributed by the local project director and medical directors with statements indicating that no compensation would be tied to performance. (See Supplementary Figure 2 , available online with this article).
Outcomes
The primary outcome was the number of duplicate chemistry tests ordered in the ED per 100 visits. Duplicate testing was defined as an order for both a laboratory basic metabolic panel and a POC chemistry study (Abbott ISTAT Chem8+; Abbott Point of Care, Inc., Princeton, New Jersey) within one hour in the ED.
Analysis
An interrupted time series approach was utilized to account for secular trends in the outcome. Because no control group was available for comparison, simple prepost analyses that assume observations are independent of one another and do not account for temporal dependency are not suitable for evaluating quality improvement strategies such as those used in the present study. 26 Instead, an autoregressive integrated moving-average (ARIMA) modeling approach was used that allows for accurate analysis of time series variables while accounting for any inherent autocorrelation in the data. 27 To ensure the appropriate selection of an ARIMA model, the augmented Dickey-Fuller (ADF) test was used to assess the dependent variable, or outcome, consisting of the number of duplicate tests per 100 ED visits by day. The ADF test for stationarity was statistically significant (P < .0001) indicating that no data transformation was necessary prior to modeling. ARIMA models using every combination of 0 to 5 autoregressive and moving average processes were tested and the model with the best fit was selected for final analysis. Model fit was compared using the Akaike information criterion (AIC), a measure of model discrimination. Results were analyzed using SAS version 9.4 (SAS Institute, Inc., Cary, North Carolina).
Results
A total of 299 701 ED visits were included over the study period: 94 051 patients received chemistry testing, 40 123 (43%) of whom underwent POC testing, 84 463 (90%) formal laboratory chemistry testing, and 16 479 (18%) duplicate chemistry testing. Prior to the intervention, a mean of 8.6 (95% confidence interval [CI]: 8.4, 8.8) patients received duplicate testing per 100 ED visits. After the intervention, a mean of 4.8 patients underwent duplicate testing (95% CI: 4.7, 4.9) per 100 ED visits (Figure 1 ).
An ARIMA (1,0,1) model was selected as the most accurate and parsimonious (AIC = 2822.204, Schwarz Bayesian criterion = 2840.679). A statistically significant decrease was found in number of duplicate tests per 100 ED visits (3.3 fewer tests per 100 ED visits, P < .0001) following the start of the intervention. There was a reduction in both the daily number of laboratory studies (1.6 fewer, P < .0001) and in POC tests (10.2 fewer, P < .0001). Reduction in duplicate testing has persisted for the 11 months since the beginning of the intervention.
Discussion
The use of a multimodal quality improvement intervention yielded substantial reductions in the overuse of blood chemistry testing in the ED. The intervention succeeded in reducing not only the primary outcome of duplicate testing, but did so by also reducing utilization of both POC and formal laboratory chemistry tests. Furthermore, these results were robust to secular trends in testing. This work demonstrates the feasibility of utilizing provider engagement to achieve meaningful reductions in unnecessary laboratory testing practices in a crowded ED setting with substantial patient and provider expectations for rapid test results and ED throughput.
Several considerations may help explain the intervention's success. Although the study team cannot identify which of the interventions yielded the greatest reductions in duplicate testing, the team believes the synergistic effect of combining several evidence-based interventions-including education, 28 EHR redesign, 29 and audit and feedback 30 -likely contributed to the intervention's success as similar multimodal approaches have been used to reduce blood culture contamination and improve hand hygiene in the ED. 31, 32 Given the complexities of knowledge translation in the ED, 33 this intervention was specifically targeted to change the knowledge, attitude, and behavioral barriers identified prior to intervention, including physician perceptions about POC test accuracy, provider overestimation of POC testing throughput benefits, and modification of the environment (both EHR as well as physical signage and prompts) to ensure success. 25, 34 The study team believes it was the combination of EHR redesign and audit and feedback in conjunction with education that allowed this intervention to achieve success where other single-modality interventions did not. 34 Furthermore, this intervention's success may have resulted from framing the objective as a choice between types of blood chemistry tests, and not as a mandate to reduce utilization that could be interpreted as reducing clinician autonomy. As such, during the intervention period ED leadership acknowledged that duplicate chemistry testing was necessary in several critical care scenarios or in the case of patients requiring expedited computed tomography (CT) imaging with intravenous contrast. Providing clinicians with such flexibility within a redesigned process ensured that ordering professionals felt confident that neither patient safety nor the timeliness of emergency care was sacrificed.
Annualized, this intervention amounts to savings of more than $126 000, more than 11 units of patient phlebotomy avoided, and numerous unmeasured indirect cost and time savings in the study ED. As POC testing in the ED becomes nearly ubiquitous, the feasibility of implementing similar interventions in other hospitals warrants discussion. 15 Because this multimodal intervention required modest resources and actions not unique to an academic or busy, urban ED, the study team believes this intervention could be feasibly scaled for implementation in less resourced EDs. Furthermore, this intervention succeeded without sacrificing staff attention to numerous existing, concurrent quality improvement initiatives common to any ED-such as "core measures" for acute myocardial infarction and pneumonia and safety initiatives to reduce central line and catheter-associated infectionsindicating that tangible results can be achieved by pairing modest attention with interventions designed to account for human factors. Based on figures available in the National Hospital Ambulatory Medical Care Survey, if baseline performance and improvements were analogous to the study hospital, more than $21 million could be saved nationally through similar reductions in duplicate chemistry testing.
As the Choosing Wisely campaign continues to move beyond provider education toward implementation, medical specialty societies should identify future targets for overuse reduction with proven evidence of improvement to ensure provider engagement. 28 In addition, health care providers seeking to reduce waste and improve the efficiency of hospital-based care should promote interventions to reduce low-value care of minimal risk to patients. Unlike the Choosing Wisely recommendations to reduce CT imaging in head injury, which faces substantial provider and patient caution and resistance because of the clinical gravity of a missed diagnosis, reductions in duplicate testing are well aligned with patient and provider interest in reduced phlebotomy, fewer spurious test results, and perhaps even lower out-of-pocket costs without incurring significant medicolegal risk. 35 These findings must be interpreted within the limitations of the study design. First, this intervention was conducted in one health system at which duplicate testing rates, and therefore the potential opportunity for improvement, may be higher or lower than at other hospitals. Second, no formal control arm was available for comparison, limiting causal inference; however, the interrupted time series approach selected is considered ideal for evaluation of similar quality improvement interventions while ensuring that implementation of the intervention most closely parallels the real world. 26, 27 In conclusion, this implementation of a multimodal quality improvement intervention yielded substantial and sustained reductions in the overuse of blood chemistry testing in the ED. This work demonstrates the feasibility of reducing low-value emergency care through local implementation of the Choosing Wisely initiative.
